SLC1A5 overexpression increases cell viability, EdU positive cell rate, invaded cell number, sphere formation efficiency, and Bcl-2 expression, while inhibits apoptosis rate and Bax expression in Silibinin-treated GBM cells (Figure 3b–i). The gene discussed is SLC1A5; the disease is glioblastoma.